Terence Flynn
Stock Analyst at Morgan Stanley
(1.97)
# 1023
Out of 5,329 analysts
202
Total ratings
64.95%
Success rate
8.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
UTHR United Therapeutics | Maintains: Equal-Weight | 346 348 | 293.57 | 18.54% | 9 | May 1, 2025 | |
ABBV AbbVie | Maintains: Overweight | 241 250 | 193.41 | 29.26% | 16 | Apr 28, 2025 | |
JNJ Johnson & Johnson | Maintains: Equal-Weight | 164 169 | 154.43 | 9.43% | 21 | Apr 16, 2025 | |
OGN Organon | Maintains: Equal-Weight | 16 15 | 9.44 | 58.9% | 9 | Apr 9, 2025 | |
LLY Eli Lilly | Maintains: Overweight | 1146 1124 | 794.79 | 41.42% | 19 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 328 330 | 283.67 | 16.33% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 48 12 | 7.24 | 65.75% | 8 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 145 139 | 102.58 | 35.5% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 69 63 | 22.56 | 179.26% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 36 25 | 8.63 | 189.69% | 5 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 30 32 | 37.73 | -15.19% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 113 106 | 83.31 | 27.24% | 16 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 17 | 11.2 | 51.79% | 4 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 56 11 | 8.66 | 27.02% | 5 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 36 39 | 49.49 | -21.2% | 10 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 31 | 23.91 | 29.65% | 17 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 118 | 27.31 | 332.08% | 1 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 36 | 3.81 | 844.88% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 48 51 | 32.49 | 56.97% | 11 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 121 168 | 99.27 | 69.24% | 6 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1 8 | 1.64 | 387.8% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 25 12 | n/a | n/a | 9 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2880 | n/a | n/a | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 246 436 | 121 | 260.33% | 3 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | n/a | n/a | 1 | Jun 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 342 | n/a | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 54 | n/a | n/a | 3 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 13, 2017 |